Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology Group

Shalini C. Reshmi(National Institutes of Health), Stephen P. Hunger(Children's Hospital of Philadelphia), Julie M. Gastier‐Foster(Nationwide Children's Hospital), Karen R. Rabin(Baylor College of Medicine), Mignon L. Loh(Seattle Children's Hospital), Marc Valentine, Zhaohui Gu(St. Jude Children's Research Hospital), Brent L. Wood(University of Washington), Elizabeth A. Raetz(NYU Langone Health), John Easton(St. Jude Children's Research Hospital), Anne Angiolillo(Children's National), Yunfeng Dai(University of Florida), Ying Shao(St. Jude Children's Research Hospital), Debbie Payne-Turner(St. Jude Children's Research Hospital), Kathryn G. Roberts(Hunter Medical Research Institute), Charles G. Mullighan(St. Jude Children's Research Hospital), Eileen Stonerock(Nationwide Children's Hospital), Cheryl L. Willman(University of New Mexico), Thai Hoa Tran(University of California, San Francisco), Richard C. Harvey(University of New Mexico), Andrew J. Carroll(University of Alabama at Birmingham), Michael J. Burke(Medical College of Wisconsin), William L. Carroll(NYU Langone Health), Meenakshi Devidas(National Institutes of Health), Jonathan V. Nguyen(University of California, San Francisco), Yu Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jinghui Zhang(St. Jude Children's Research Hospital), Yongjin Li(St. Jude Children's Research Hospital), I‐Ming Chen(University of New Mexico), Amy Smith(Nationwide Children's Hospital), Michael J. Borowitz, Nyla A. Heerema(The Ohio State University), Wanda L. Salzer(Maine Medical Center), Heather Jenkins(Nationwide Children's Hospital), Patrick A. Zweidler‐McKay(The University of Texas MD Anderson Cancer Center)
Blood
April 13, 2017
Cited by 305


Related Papers